{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T15:08:56Z","timestamp":1771945736964,"version":"3.50.1"},"reference-count":12,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T00:00:00Z","timestamp":1771891200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Ventricular septal defect (VSD) is among the most prevalent congenital heart diseases, accounting for approximately 20%\u201330% of cases. Mainstay treatments encompass interventional closure and surgical repair. The conventional interventional approach necessitates puncturing both the femoral artery and vein to establish an arteriovenous circuit for device delivery. While markedly less invasive than open-heart surgery, this method carries inherent risks, including sheath compression challenges, conduction block, injury to valvular chordae tendineae, and vascular complications.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case description<\/jats:title>\n                    <jats:p>To enhance procedural safety while maintaining efficacy, our center pioneered a transcatheter single-access closure technique for VSD, performed under fluoroscopic and echocardiographic guidance in two patients. This \u201csingle\u201d strategy proved successful in both instances. The procedures were well-tolerated, with patients achieving ambulation on the same day, experiencing stable perioperative periods, and demonstrating favorable early recovery outcomes. Immediate and one-month follow-up transthoracic echocardiography confirmed stable device position, with no evidence of residual shunt or new-onset valvular regurgitation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>These case reports preliminarily indicate that the transcatheter single-access VSD closure technique is technically feasible and demonstrates a favorable early safety profile. While limited in scale, the successful outcomes in these two cases suggest significant promise for broader clinical adoption. However, further validation through larger-scale studies and long-term follow-up is required to confirm its sustained efficacy and safety.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fcvm.2026.1774886","type":"journal-article","created":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T14:22:03Z","timestamp":1771942923000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Case Report: Transcatheter closure of ventricular septal defect using a Starway Neo Occluder via a single-access approach: report of two cases"],"prefix":"10.3389","volume":"13","author":[{"given":"Changjing","family":"Huang","sequence":"first","affiliation":[{"name":"Center for Cardiovascular Diseases, Meizhou People\u2019s Hospital, Meizhou Academy of Medical Sciences","place":["Meizhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nan","family":"Cai","sequence":"additional","affiliation":[{"name":"Center for Cardiovascular Diseases, Meizhou People\u2019s Hospital, Meizhou Academy of Medical Sciences","place":["Meizhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Youqian","family":"Li","sequence":"additional","affiliation":[{"name":"Center for Cardiovascular Diseases, Meizhou People\u2019s Hospital, Meizhou Academy of Medical Sciences","place":["Meizhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weike","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Ultrasound, Meizhou People\u2019s Hospital, Meizhou Academy of Medical Sciences","place":["Meizhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingfeng","family":"Liu","sequence":"additional","affiliation":[{"name":"Center for Cardiovascular Diseases, Meizhou People\u2019s Hospital, Meizhou Academy of Medical Sciences","place":["Meizhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haifeng","family":"Hong","sequence":"additional","affiliation":[{"name":"Center for Cardiovascular Diseases, Meizhou People\u2019s Hospital, Meizhou Academy of Medical Sciences","place":["Meizhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guodong","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Interventional Medicine, Meizhou People\u2019s Hospital, Meizhou Academy of Medical Sciences","place":["Meizhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhihui","family":"Hu","sequence":"additional","affiliation":[{"name":"Center for Cardiovascular Diseases, Meizhou People\u2019s Hospital, Meizhou Academy of Medical Sciences","place":["Meizhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Zhong","sequence":"additional","affiliation":[{"name":"Center for Cardiovascular Diseases, Meizhou People\u2019s Hospital, Meizhou Academy of Medical Sciences","place":["Meizhou, China"]},{"name":"GuangDong Engineering Technological Research Center of Molecular Diagnosis in Cardiovascular Diseases","place":["Meizhou, China"]},{"name":"Meizhou Key Laboratory of Cardiovascular Translational Medicine","place":["Meizhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,2,24]]},"reference":[{"key":"B1","first-page":"38","article-title":"Guidelines for percutaneous interventional therapy of common congenital heart disease (2021 edition)","volume-title":"Natl Med J China","year":"2021"},{"key":"B2","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1161\/01.CIR.78.2.361","article-title":"Transcatheter closure of ventricular septal defects","volume":"78","author":"Lock","year":"1988","journal-title":"Circulation"},{"key":"B3","first-page":"3","article-title":"Analysis of complications of interventional therapy for ventricular septal defect","volume":"33","author":"Zhang","year":"2021","journal-title":"Chin Heart J"},{"key":"B4","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1007\/s00246-006-1365-5","article-title":"Retrograde approach for device closure of muscular ventricular septal defects in children and adolescents, using the amplatzer muscular ventricular septal defect occluder","volume":"27","author":"Jameel","year":"2006","journal-title":"Pediatr Cardiol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"461","DOI":"10.14744\/AnatolJCardiol.2017.7507","article-title":"Directly ventricular septal defect closure without using arteriovenous wire loop: our adult case series using transarterial retrograde approach","volume":"17","author":"Pekel","year":"2017","journal-title":"Anatol J Cardiol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1007\/s00246-021-02638-6","article-title":"Transcarotid approach to ventricular septal defect closure in small infants","volume":"42","author":"Breatnach","year":"2021","journal-title":"Pediatr Cardiol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1017\/S1047951117002396","article-title":"Transcatheter closure of congenital perimembranous ventricular septal defect using the amplatzer duct occluder 2","volume":"28","author":"Zhao","year":"2018","journal-title":"Cardiol Young"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1017\/S1047951122003407","article-title":"Transcatheter closure of large perimembranous ventricular septal defects with inlet to outlet extension with the amplatzer vascular plug-II","volume":"33","author":"Piccinelli","year":"2023","journal-title":"Cardiol Young"},{"key":"B9","first-page":"63","article-title":"Chinese Expert consensus on cerebrovascular interventional procedures via transradial or distal transradial access","volume":"20","year":"2023","journal-title":"Chin J Cerebrovasc Dis"},{"key":"B10","first-page":"4","article-title":"Efficacy evaluation of the second-generation amplatzer patent ductus arteriosus occluder for ventricular septal defect closure via femoral artery retrograde catheterization","volume":"30","author":"Gejun","year":"2015","journal-title":"Clin Focus"},{"key":"B11","first-page":"4","article-title":"Interventional therapy for membranous aneurysm-type ventricular septal defect","volume":"15","author":"Qin","year":"2006","journal-title":"J Interv Radiol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1016\/j.recesp.2025.02.015","article-title":"MIOS-MFO, a multicenter international observational study of the lifetech KONAR-MF ventricular septal defect occluder in treating perimembranous ventricular septal defects","volume":"78","author":"Haddad","year":"2025","journal-title":"Rev Esp Cardiol (Engl Ed)"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1774886\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T14:22:07Z","timestamp":1771942927000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1774886\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,24]]},"references-count":12,"alternative-id":["10.3389\/fcvm.2026.1774886"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2026.1774886","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,24]]},"article-number":"1774886"}}